Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19;14(1):28586.
doi: 10.1038/s41598-024-80289-2.

Hospitalizations and deaths among people coinfected with HIV and HCV

Affiliations

Hospitalizations and deaths among people coinfected with HIV and HCV

Dorota Zarębska-Michaluk et al. Sci Rep. .

Abstract

Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) remains a significant public health challenge. This retrospective, population-based study assessed the trends in hospitalization rates among patients co-infected with HCV and HIV in Poland in 2012-2022, encompassing the COVID-19 pandemic and massive influx of war refugees from Ukraine, the demographics and clinical characteristics among hospitalized patients, including in-hospital case fatality rates. Most hospitalized patients were over 40 years old (mean ± SD: 41.7 ± 8.9 years) and were men (74%). The mean annual hospitalization rate was estimated at 1.33 per 105 and was three-fold lower in the pandemic period (mean 0.51 per 105) than in the pre-pandemic era (mean 1.63 per 105). In turn, the in-hospital case-fatality rates increased during the pandemic in men (from a mean of 1.83 to 3.93) but not in women (a mean of 1.53 in both periods). There was no significant increase in hospitalization rates in 2022, during which the significant inflow of war refugees in Ukraine occurred. The epidemiological situation of people (co)infected with HIV and HCV in Poland requires further monitoring, though it did not escalate in the studied period due to the influx of war refugees from Ukraine.

Keywords: COVID-19 pandemic; Epidemiology; Hepatitis C; Sexually-transmitted disease.

PubMed Disclaimer

Conflict of interest statement

Declarations Competing interests The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
(A) Hospitalization of patients co-infected with HCV and HIV per year in 2012–2022 and (B) their age distribution.
Fig. 2
Fig. 2
In-hospital case fatality rates (CFR) for patients co-infected with HCV and HIV per month in 2012–2022.

Similar articles

Cited by

References

    1. Gobran, S. T., Ancuta, P. & Shoukry, N. H. A tale of two viruses: Immunological insights into HCV/HIV coinfection. Front Immunol ,12. (2021). 10.3389/fimmu.2021.726419 - PMC - PubMed
    1. Nkolola, J. P. & Barouch, D. H. Prophylactic HIV-1 vaccine trials: past, present, and future. Lancet HIV11, e117–e124 (2024). - PMC - PubMed
    1. Rzymski, P. et al. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches. J. Med. Virol. [Internet]. ; (2024). 10.1002/jmv.29900 - PubMed
    1. Alter, M. J. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol.44, S6–9 (2006). - PubMed
    1. Jin, F. et al. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol.6, 39–56 (2021). - PubMed

MeSH terms

LinkOut - more resources